Coverage from the Annual Meeting and Exposition of the American Society of Hematology, which took place December 9-12, 2017, in Atlanta, Ga., is available in a special recap issue of Evidence-Based Oncology™.
If you missed the American Society of Hematology (ASH) 2017, or you want to review major findings, the meeting recap is now available in Evidence-Based Oncology™, a publication of The American Journal of Managed Care® (AJMC®). You can find the full issue at ajmc.com.
AJMC® Associate Editorial Director Surabhi Dangi-Garimella, PhD, leads off the issue with updates from the JULIET and ZUMA-1 trials, which led to approvals for the world’s first chimeric antigen receptor (CAR) T-cell therapies: Kymriah to treat pediatric acute lymphoblastic leukemia, and Yescarta to treat certain types of non-Hodgkin lymphoma. Both therapies are being studied in other blood cancers.
Dr. Dangi-Garimella also discusses a critical question in cancer care: as clinicians and patients balance the benefits and potential toxicities of therapies, when should treatment stop? This was addressed in the session, “Treatment-Free Remission and Cardiotoxicity: the Future of CML Care.”
Featured quality-of-life studies include:
A study of rituximab use found that financial incentives may encourage overuse of the cancer drug in the community setting.
The issue features new results for ibrutinib, the ECHELON-1 study, additional coverage on the cost of care and a section on biosimilars. The issue also includes interviews with experts that also appear online at www.ajmc.com/conferences/ash-2017.
About The American Journal of Managed Care®:
The American Journal of Managed Care® (AJMC®) is a peer-reviewed, MEDLINE-indexed journal that keeps readers on the forefront of health policy by publishing research relevant to industry decision makers as they work to promote the efficient delivery of high-quality care. AJMC.com is the essential website for managed care professionals, distributing industry updates daily to leading stakeholders. Other titles in the AJMC® family include The American Journal of Accountable Care®, and two evidence-based series, Evidence-Based Oncology™ and Evidence-Based Diabetes Management™. These comprehensive offerings bring together stakeholder views from payers, providers, policymakers and other industry leaders in managed care. To order reprints of articles appearing in AJMC® publications, please contact Jeff Prescott at 609-716-7777, ext. 331.
Theresa Burek, 609-716-7777